EyePoint Plc (EYPT)
15.33
+0.63
(+4.29%)
USD |
NASDAQ |
Feb 20, 16:00
15.34
+0.01
(+0.07%)
After-Hours: 20:00
EyePoint SG&A Expense (Quarterly) : 14.52M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Ocular Therapeutix, Inc. | 30.62M |
| Viking Therapeutics, Inc. | 11.28M |
| Janux Therapeutics, Inc. | 10.62M |
| Tango Therapeutics, Inc. | 8.924M |